Login / Signup

A M1 muscarinic acetylcholine receptor positive allosteric modulator improves pathology and cognitive deficits in female APPswe/PSEN1ΔE9 mice.

Khaled S Abd-ElrahmanShaarika SarasijaTash-Lynn L ColsonStephen S G Ferguson
Published in: British journal of pharmacology (2021)
Using M1 mAChR PAMs can be a viable disease-modifying approach that should be exploited clinically to slow AD in women.
Keyphrases
  • polycystic ovary syndrome
  • early onset
  • small molecule
  • high fat diet induced
  • pregnancy outcomes
  • cervical cancer screening
  • breast cancer risk
  • wild type
  • binding protein